Brief: PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
21/08/2024 14:14
Aug 21 (Reuters) - Quest Diagnostics Inc DGX.N :
* PRECISEDX: RAISED $20.7 MILLION IN SERIES B FUNDING,
BRINGING
TOTAL FUNDING TO DATE TO $31.5 MILLION
* PRECISEDX: ADDITIONAL PARTICIPANTS IN ROUND INCLUDE
LABCORP,
QUEST DIAGNOSTICS, GENHENN CAPITAL VENTURE
Source text for Eikon: ID:nPn3k2YGBa
Further company coverage: DGX.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Labcorp Holdings
See all newsBrief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health
U.S. STOCKS ON THE MOVE-Royal Caribbean, Labcorp, Textron